NYSE:RAD - Rite Aid Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $13.67
  • Forecasted Upside: -31.32 %
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.77 (-3.73%)

This chart shows the closing price for RAD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Rite Aid Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RAD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RAD

Analyst Price Target is $13.67
▼ -31.32% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Rite Aid in the last 3 months. The average price target is $13.67, with a high forecast of $18.00 and a low forecast of $6.00. The average price target represents a -31.32% upside from the last price of $19.90.

This chart shows the closing price for RAD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 contributing investment analysts is to hold stock in Rite Aid. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/22/2021Deutsche Bank AktiengesellschaftLower Price TargetHold$27.00 ➝ $18.00High
6/9/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
3/25/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$17.00 ➝ $27.00High
12/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$9.00 ➝ $17.00High
9/25/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$18.00 ➝ $9.00High
9/24/2020Evercore ISIBoost Price TargetUnderperform$4.00 ➝ $6.00High
6/26/2020JPMorgan Chase & Co.Boost Price TargetNeutral$12.00 ➝ $17.00High
6/26/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$12.00 ➝ $18.00High
4/17/2020Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold$12.00Low
2/27/2020GuggenheimUpgradeSell ➝ NeutralHigh
12/23/2019Deutsche Bank AktiengesellschaftBoost Price TargetSell$5.00 ➝ $12.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageSell$5.00High
8/12/2019Evercore ISIReiterated RatingSellHigh
4/18/2019GuggenheimReiterated RatingSell ➝ SellHigh
12/20/2018Loop CapitalLower Price TargetHold$27.00 ➝ $20.00High
9/28/2018Loop CapitalSet Price TargetHold$20.00Low
9/24/2018Royal Bank of CanadaSet Price TargetHold$20.00Low
9/6/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$20.00High
8/13/2018CowenDowngradeOutperform ➝ Market Perform$47.00 ➝ $120.00High
8/9/2018MizuhoReiterated RatingHold$40.00Low
6/28/2018CowenReiterated RatingBuy$47.00High
4/17/2018MizuhoReiterated RatingHoldMedium
1/4/2018Evercore ISIInitiated CoverageUnderperform ➝ Underperform$30.00Medium
12/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$45.00Medium
10/25/2017Royal Bank of CanadaSet Price TargetHold$40.00N/A
10/7/2017MizuhoSet Price TargetHold$40.00N/A
10/6/2017MizuhoLower Price TargetNeutral ➝ Neutral$59.00 ➝ $45.00N/A
10/2/2017GuggenheimReiterated RatingNeutral$40.00Low
9/29/2017Loop CapitalReiterated RatingHold ➝ Hold$50.00 ➝ $40.00High
9/19/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$50.00High
9/11/2017Loop CapitalInitiated CoverageHold ➝ Hold$50.00High
7/20/2017MizuhoDowngradeBuy ➝ Neutral$59.00Medium
7/3/2017GuggenheimReiterated RatingNeutralHigh
7/3/2017CowenReiterated RatingOutperform$94.00High
6/30/2017Bank of AmericaReiterated RatingUnderperform$40.00High
6/30/2017Evercore ISIInitiated CoverageSell ➝ Underperform$50.00High
6/12/2017CowenReiterated RatingOutperform$94.00Medium
4/25/2017GuggenheimDowngradeBuy ➝ NeutralMedium
3/20/2017Credit Suisse GroupReiterated RatingOutperform$130.00Low
3/6/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$180.00 ➝ $130.00N/A
1/31/2017MizuhoLower Price Target$135.00N/A
1/30/2017MizuhoReiterated RatingPositive$180.00 ➝ $135.00N/A
(Data available from 6/23/2016 forward)
Rite Aid logo
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, pet care, and other every day and convenience products, as well as brand and generic prescription drugs. It also operates retail clinics that provide treatment for common conditions; and provides preventative services. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of April 28, 2021, the company operated approximately 2,500 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania.
Read More

Today's Range

Now: $19.90
Low: $19.52
High: $20.45

50 Day Range

MA: $19.11
Low: $16.80
High: $22.53

52 Week Range

Now: $19.90
Low: $8.85
High: $32.48


1,634,612 shs

Average Volume

2,336,742 shs

Market Capitalization

$1.10 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Rite Aid?

The following equities research analysts have issued reports on Rite Aid in the last twelve months: Deutsche Bank Aktiengesellschaft, Evercore ISI, JPMorgan Chase & Co., TheStreet, and Zacks Investment Research.
View the latest analyst ratings for RAD.

What is the current price target for Rite Aid?

3 Wall Street analysts have set twelve-month price targets for Rite Aid in the last year. Their average twelve-month price target is $13.67, suggesting a possible downside of 31.3%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting RAD will reach $18.00 in the next twelve months. Evercore ISI has the lowest price target set, forecasting a price of $6.00 for Rite Aid in the next year.
View the latest price targets for RAD.

What is the current consensus analyst rating for Rite Aid?

Rite Aid currently has 1 sell rating and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RAD, but not buy more shares or sell existing shares.
View the latest ratings for RAD.

What other companies compete with Rite Aid?

How do I contact Rite Aid's investor relations team?

Rite Aid's physical mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company's listed phone number is 717-761-2633 and its investor relations email address is [email protected] The official website for Rite Aid is www.riteaid.com.